Dr | Research Officer+61 7 3845 3741
After completing her Bachelor of Biotechnology (1st class Honours) at the University of Tasmania in 2008, Dr Simmons moved north to Brisbane. In 2009, she commenced her PhD in the Signal Transduction Laboratory at QIMR Berghofer as a student of the University of Queensland. Her research during this time focused on the centrosomal protein CEP55 and how it contributed to breast cancer initiation and progression.
Following completion of her PhD in 2013, Dr Simmons started work as a Postdoc in the newly established Cancer Drug Mechanisms Laboratory at QIMR Berghofer. Her research focuses on melanoma, a form of skin cancer which is nearly impossible to treat once it spreads beyond the skin. Dr Simmons is interested in the proteins directly involved in the metastatic process and in particular the key transcription factors MITF and BRN2. Her research is moving towards using three-dimensional models to understand how/why metastatic melanoma is so resistant to therapy and finding ways to overcome therapy resistance.
2013-current: Research Officer
2019-current: Adjunct Associate Professor, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology
2020-current: Honorary Fellow, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland.
2018-2019: Graduate Development Officer, QIMR Berghofer
2009-2013: PhD Student, Signal Transduction Lab, QIMR Berghofer
2010-2012: Laboratory Assistant, QPharm Pty Ltd
ORCID number: 0000-0002-9311-1046
Researcher ID: S-2373-2018
2013: PhD – Breast Cancer Cell Biology, The University of Queensland
2008: Bachelor of BioTechnology (1st Class honours) – Molecular biology and microbiology, The University of Tasmania